Study of pharmacological activity of dry extract of sakhalin willow shoots against the background of experimental thrombophlebitis

Authors

DOI:

https://doi.org/10.15587/2519-4852.2023.286723

Keywords:

dry extract of Sakhalin willow shoots, experimental thrombophlebitis, inflammatory process, pharmacological activity, rabbits

Abstract

The aim. The objective of the research was to study the pharmacological activity of dry extract of Sakhalin willow shoots – DEWS against the background of experimental thrombophlebitis.

Materials and methods. Dry extract of Sakhalin willow shoots (DEWS) was the object matter of the present research and served as a therapeutic and prophylactic agent. In the experiment conducted, rabbits weighing 2.0 – 2.5 kg were used. The animals were divided into three groups. Group 1 was a control group; group 2 were animals that had been intragastrically injected with DEWS at a dose of 30 mg/kg prior to modelling thrombophlebitis; group 3 similarly received Eskuvit 20 mg/kg as a reference drug – pills (JSC Halychpharm, Ukraine). The dose for animals was recalculated, taking into account body weight according to the Rybolovlev method.

Experimental thrombophlebitis was caused by injecting an intravenous solution of 2 % lugol at a dose of 0.1 ml into the marginal vein of the ear. Statistical data processing was carried out using the Statistica for Windows 11.0 program based on variance analysis for repeated measurement data using the Mann-Whitney criteria at a probability level of p<0.05.

Results. Against the background of the development of experimental thrombophlebitis in rabbits, the development of thrombosis of the ear vein and the inflammatory process of adjacent tissues were observed. The inflammatory process was accompanied by pronounced hyperemia and oedema. Prophylactic administration of DEWS for 6 days contributed to a decrease in the inflammatory process already on the 5th day of observation. The area of the injured area was 20 % smaller than in the control pathology group. The therapeutic and prophylactic effect of herbal medicine can be explained by the content of flavonoids and salicylates in its composition. Eskuvit showed a less pronounced thrombolytic effect in terms of its influence on thrombosis and thrombolysis.

Conclusions. The administration of DEWS in the therapeutic and prophylactic regimen at a dose of 30 mg/kg has a pronounced anti-inflammatory, thrombolytic and venoprotective effect in experimental peripheral venous thrombophlebitis in rabbits. The results of the studies obtained allow us to recommend DEWS as a promising venoprotective agent with thrombolytic activity

Author Biographies

Liudmyla Maloshtan, National University of Pharmacy

Doctor of Biological Sciences, Professor

Department of Biological Chemistry

Kateryna Artemova, National University of Pharmacy

Department of Technologies of Pharmaceutical preparations

Natalia Borodina, National University of Pharmacy

Doctor of Pharmaceutical Sciences, Head of Department

Department of Technologies of Pharmaceutical Preparations

Oleksandr Kukhtenko, National University of Pharmacy

Doctor of Pharmaceutical Sciences, Professor, Head of Department

Department of Technologies of Pharmaceutical Preparations

References

  1. ASH Releases New Clinical Practice Guidelines for Venos Tromboemboligm. Evidence-Based Guidelines to Drive Improved Care for Patients with Bood Clots (2018). Washington.
  2. Sandor, T. (2017). Superficial venous thrombosis. A state of art. Orvosi Hetilap, 158 (4), 129–138.
  3. Raffetto, J. D., Eberhardt, R. T. (2015). Benefit of anticoagulation for the treatment of lower extremity superficial venous thrombosis. Journal of Vascular Surgery: Venous and Lymphatic Disorders, 3 (2), 236–241. doi: https://doi.org/10.1016/j.jvsv.2014.11.005
  4. Dmitrieva, I., Krivoshchekov, E. (2018). Flebological help patients with complicated forms of chronic venous insufficitney 24 Conference of the European Wound Management Association EWMA. Madrid, 360.
  5. Galanaud, J. ‐P., Sevestre, M. ‐A., Pernod, G., Kahn, S. R., Genty, C., Terrisse, H. et al. (2017). Long‐term risk of venous thromboembolism recurrence after isolated superficial vein thrombosis. Journal of Thrombosis and Haemostasis, 15 (6), 1123–1131. doi: https://doi.org/10.1111/jth.13679
  6. Shevela, A. I., Usov, S. A., Markina, V. A. (2019). Obesity and Chronic Venous Insufficiency: from Risk Factors to Pathogenesis. Flebologiia, 13 (3), 220–226. doi: https://doi.org/10.17116/flebo201913031220
  7. Pannier, F., Rabe, E. (2015). Progression in venous pathology. Phlebology: The Journal of Venous Disease, 30 (1), 95–97. doi: https://doi.org/10.1177/0268355514568847
  8. Zhao, J., Maitituersun, A., Li, C., Li, Q., Xu, F., Liu, T. (2018). Evaluation on Analgesic and Anti-Inflammatory Activities of Total Flavonoids from Juniperus sabina. Evidence-Based Complementary and Alternative Medicine, 2018, 1–9. doi: https://doi.org/10.1155/2018/7965306
  9. Le, N., Herz, C., Gomes, J., Förster, N., Antoniadou, K., Mittermeier-Kleßinger, V. et al. (2021). Comparative Anti-Inflammatory Effects of Salix Cortex Extracts and Acetylsalicylic Acid in SARS-CoV-2 Peptide and LPS-Activated Human In Vitro Systems. International Journal of Molecular Sciences, 22 (13), 6766. doi: https://doi.org/10.3390/ijms22136766
  10. Borodina, N. V. (2021). Pharmacognostic study of willow plants and creation of medicines based on them. Kharkiv, 575.
  11. Sinchenka, V. M. (Ed.) (2015). Enerhetychna verba: tekhnolohiia vyroshchuvannia ta vykorystannia. Vinnytsia: TOV «Niland-LTD», 340.
  12. Vorobei, V., Melekh, Ya., Hudz, N. (2018). Vykorystannia biomasy enerhetychnykh kultur u pivnichnykh oblastiakh Ukrainy: Volynska, Rivnenska, Zhytomyrska, Kyivska ta Chernihivska oblasti. Lviv, 59.
  13. Energeticheskaia verba: kak vyrastit i skolko na etom mozhno zarabotat znaiut na Rovenshchine (2016). Available at: https://ecotechnica.com.ua/…/708-energeticheskaya-verba-kak…
  14. Borodina, N., Raal, A., Kovalyov, V., Koshovyi, О., Ilina, T. (2020). Macro- and Microelements in the Branches of some Salix Genus Species in the Flora of Ukraine. International Journal of Pharmaceutical Research & Allied Sciences, 9 (3), 71–80.
  15. Borodina, N., Kovalyov, V., Koshovyi, О. (2021). Reserch of raw material and extracts of salixsachalinensis. F. Schmidt. Norwegian Journal of development of the International Science, 1 (55), 42–47.
  16. Borodina, N. V., Kovalov, V. M., Stremoukhov, O.O. (2015). Pat. No. 98912 UA. Sposib oderzhannia kompleksnoho sukhoho ekstraktu z roslynnoi syrovyny. No u201413010; declareted: 04.12.2014; published: 12.05.2015, Bul. No. 9.
  17. Borodina, N. V., Kovalev, V. N. (2015). Comparative analysis of phenolic compounds shoots Salix caprea L., Salix purpurea L., Salix viminalis L. Flora of Ukraine. Fenolnye soedineniia: fundamentalnye i prikladnye aspekty. Moscow, 27–33.
  18. Maloshtan, L. M., Artemova, K. O., Shatalova, O. M. (2021). Study of analgesic and anti-inflammatory activity of dry extract from sakhalin willow shoots. Farmatsevtychnyi Zhurnal, 4, 103–110. doi: https://doi.org/10.32352/0367-3057.4.21.09
  19. Maloshtan, L. M., Kalenichenko, G. S., Dorovskyy, O. V. (2015). The study of the action of the thick extract from the leaves of Corylus avellana on the vascular tissue permeability. Clinical pharmacy, 19 (4), 26–29. doi: https://doi.org/10.24959/cphj.15.1362
  20. Gloviczki, P., Comerota, A. J., Dalsing, M. C., Eklof, B. G., Gillespie, D. L., Gloviczki, M. L. et al. (2011). The care of patients with varicose veins and associated chronic venous diseases: Clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. Journal of Vascular Surgery, 53 (5), 2S-48S. doi: https://doi.org/10.1016/j.jvs.2011.01.079
  21. Guyatt, G. H., Akl, E. A., Crowther, M., Gutterman, D. D., Schuünemann, H. J. (2012). Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 141 (2), 7S-47S. doi: https://doi.org/10.1378/chest.1412s3
  22. Rybolovlev, Iu. R., Rybolovlev, R. S. (1979). Dozirovanie veshchestv dlia mlekopitaiushchikh po konstantam biologicheskoi aktivnosti. Doklady AN SSSR, 247 (6), 1513–1516.
  23. Evropeiskaia konventciia o zashchite pozvonochnykh zhivotnykh, ispolzuemykh dlia eksperimentov ili v inykh nauchnykh tceliakh (1986). Available at: https://rm.coe.int/168007a6a8
  24. Ekspertnyi vysnovok komisii z bioetyky (2019). Natsionalnyi farmatsevtychnyi universytet, m. Kharkiv, protokol No. 6.
  25. Maloshtan, L. M., Dolzhykova, O. V., Batura, I. O. (2002). Sposib modeliuvannia tromboflebitiv pereferiinykh sudyn: informatsiinyi lyst vid 20.11.2002 r. No. 251. Kyiv: Ukrmedpatentprom, 3.
  26. Khabriev, R. U. (2005). Rukovodstvo po eksperimentalnomu (doklinicheskomu) izucheniiu novykh farmakologicheskikh veshchestv. Moscow: OAO «Izdatelstvo «Meditcina», 832.
  27. Lobastov, K. V., Dementieva, G. I., Laberko, L. A. (2019). Current Insights on the Etiology and Pathogenesis of Venous Thrombosis: Virchow's Triad Revision. Flebologiia, 13 (3), 227–235. doi: https://doi.org/10.17116/flebo201913031227
  28. Kurkin, V., Zaitseva, Е., Morozova, Т., Pravdivtseva, О., Avdeeva, Е., Kurkina, А. et al. (2018). The study of the flavonoids and antidepressant activity of the leaves and liquid ex-tract of crataegus submollis. Chemistry of Plant Raw Material, 4, 105–112. doi: https://doi.org/10.14258/jcprm.2018043883
  29. Kurkin, V. A., Zaitceva, E. N., Morozova, T. V., Pravdivtseva, O. E., Dubishchev, A. V., Kurkina, A. V. et al. (2019). Comparative Investigation of the Diurethic and Anti-Depressant Activity of Liquid Extracts of Crataegus Sanguinea. Journal of Pharmaceutical Sciences and Research, 11 (1), 30–32.

Downloads

Published

2023-08-31

How to Cite

Maloshtan, L., Artemova, K., Borodina, N., & Kukhtenko, O. (2023). Study of pharmacological activity of dry extract of sakhalin willow shoots against the background of experimental thrombophlebitis. ScienceRise: Pharmaceutical Science, (4(44), 97–103. https://doi.org/10.15587/2519-4852.2023.286723

Issue

No. 4(44) (2023)

Section

Pharmaceutical Science

License

Copyright (c) 2023 Natalia Borodina, Liudmyla Maloshtan, Kateryna Artemova, Oleksandr Kukhtenko

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our journal abides by the Creative Commons Attribution 4.0 International License copyright rights and permissions for open access journals.

Authors, who are published in this journal, agree to the following conditions:

1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.

 2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.

3. Authors have the right to store the final accepted version of the article in an institutional, thematic, or any other repository to ensure visibility and accessibility.